Anfield Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Anfield Capital Management's NVS Position: Q1 2026 in Review
Anfield Capital Management opened a new position in Novartis (NVS) in Q1 2026: 284 shares worth $43.4K. The stake represents 0.01% of the portfolio and ranks #270 among its holdings. This is a return to the name: Anfield Capital Management previously reported a position in NVS as recently as Q2 2021.
Anfield Capital Management first reported a position in NVS in Q4 2019 and has held it in 3 quarters since. The position peaked at $80K in Q4 2019. 1,599 funds tracked by Wall St. Rank hold NVS as of Q1 2026.
- Anfield Capital Management held 284 shares of Novartis worth $43.4K as of Q1 2026.
- Novartis was a new Anfield Capital Management position in Q1 2026.
- Novartis made up 0.01% of Anfield Capital Management's portfolio in Q1 2026, its #270 holding.
- Anfield Capital Management first reported a position in Novartis in Q4 2019 and has held it in 3 quarters since.
- Anfield Capital Management's Novartis position peaked at $80K in Q4 2019.
- 1,599 funds tracked by Wall St. Rank held Novartis as of Q1 2026.
Based on Anfield Capital Management's 13F filing for Q1 2026, filed 12 May 2026.